Significant associations in GWAS. حسب Dai Nogimura (21445649)

الموضوعات:

Bias risk assessments for each RCT study. حسب Xin Liu (43569)

الموضوعات:

The flow chart of studies selecting. حسب Xin Liu (43569)

الموضوعات:

Forest plot of the effect of high-dose TXA on transfusion rate. حسب Xin Liu (43569)

الموضوعات:

Forest plot of the effect of high-dose TXA on intraoperative blood loss. حسب Xin Liu (43569)

الموضوعات:

Forest plot of the effect of high-dose TXA on operation time. حسب Xin Liu (43569)

الموضوعات:

Characteristics of the included studies. حسب Xin Liu (43569)

الموضوعات:

Funnel plots for intraoperative blood loss. حسب Xin Liu (43569)

الموضوعات:

Bias risk assessments for each RCS study. حسب Xin Liu (43569)

الموضوعات:

Summary of results. حسب Xin Liu (43569)

الموضوعات:

Prisma flow diagram of study selection. حسب Hattapark Dejakaisaya (22238613)

الموضوعات:

Significant Decrease in Vessel Count of Trade Vessels in (a) Bosporus Strait and (b) Bab el-Mandeb Strait. حسب Cherryl Chico (20978829)

Parvalbumin-positive interneurons (PV-INs) in perilesional tissue respond to optogenetic stimulation and are involved in voluntary movement, but show a decreased firing rate. حسب Livia Vignozzi (22430567)

"…<b>E</b>, Quantification of the average firing rate of the recorded PV-INs in response to optogenetic stimulation. A significant decrease in firing activity is evident in stroke animals (Two-tailed <i>T</i> Test *** <i><i>P</i></i> < 0.001). …"

Blood Pressure and LDL-C During Follow-up. حسب Karl Ingard (22582091)

الموضوعات:

Median EQ-5D-3L index values during 5 years of follow-up. حسب Karl Ingard (22582091)

الموضوعات:

Baseline Characteristics of Included Patients. حسب Karl Ingard (22582091)

الموضوعات:

Subgroup Analysis of the Occurrence of Secondary Endpoints. حسب Karl Ingard (22582091)

الموضوعات:

Study flow chart. حسب Karl Ingard (22582091)

الموضوعات:

Kaplan-Meier curve of the primary outcome. حسب Karl Ingard (22582091)

الموضوعات:

Number of Patients Who Reached the Primary and Secondary Endpoints During Follow-up. حسب Karl Ingard (22582091)

الموضوعات: